0001104659-21-113036.txt : 20210907 0001104659-21-113036.hdr.sgml : 20210907 20210903185137 ACCESSION NUMBER: 0001104659-21-113036 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210907 DATE AS OF CHANGE: 20210903 EFFECTIVENESS DATE: 20210907 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bakx Therapeutics, Inc. CENTRAL INDEX KEY: 0001876494 IRS NUMBER: 851864174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-412464 FILM NUMBER: 211237843 BUSINESS ADDRESS: STREET 1: 551 MT GUARDIAN RD EXT STREET 2: PO BOX 398 CITY: BEARSVILLE STATE: NY ZIP: 12409 BUSINESS PHONE: (718) 419-5221 MAIL ADDRESS: STREET 1: 551 MT GUARDIAN RD EXT STREET 2: PO BOX 398 CITY: BEARSVILLE STATE: NY ZIP: 12409 D 1 primary_doc.xml X0708 D LIVE 0001876494 Bakx Therapeutics, Inc. 551 MT GUARDIAN RD EXT BEARSVILLE NY NEW YORK 12409 (718) 419-5221 DELAWARE None None Corporation true 2020 Sree Kant 551 Mt Guardian Rd Ext PO Box 398 Bearsville NY NEW YORK 12409 Executive Officer Director Promoter Yibing Shan c/o Bakx Therapeutics Inc. 551 Mt Guardian Rd Ext, PO Box 398 Bearsville NY NEW YORK 12409 Director Ervis Gavathiotis c/o Bakx Therapeutics Inc. 551 Mt Guardian Rd Ext, PO Box 398 Bearsville NY NEW YORK 12409 Executive Officer Promoter Loren Walensky c/o Bakx Therapeutics Inc. 551 Mt Guardian Rd Ext, PO Box 398 Bearsville NY NEW YORK 12409 Executive Officer Promoter Jessie English c/o Bakx Therapeutics Inc. 551 Mt Guardian Rd Ext, PO Box 398 Bearsville NY NEW YORK 12409 Executive Officer Promoter Frances Toneguzzo c/o Bakx Therapeutics Inc. 551 Mt Guardian Rd Ext, PO Box 398 Bearsville NY NEW YORK 12409 Promoter Phillippe Lopes-Fernandes 65 Quai George Gorse Boulonge-Billancourt I0 FRANCE 92100 Director Biotechnology Decline to Disclose 06b false 2021-08-20 false true true false 0 34255728 20255728 14000000 Amount sold includes $4,255,728 attributable to Notes converted to Series A Preferred Stock. false 3 0 0 0 false Bakx Therapeutics, Inc. /s/ Sree Kant Sree Kant Chief Executive Officer 2021-09-01